These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 33545421)

  • 21. Detection of an IncA/C plasmid encoding VIM-4 and CMY-4 β-lactamases in Klebsiella oxytoca and Citrobacter koseri from an inpatient in a cardiac rehabilitation unit.
    Caltagirone M; Bitar I; Piazza A; Spalla M; Nucleo E; Navarra A; Migliavacca R
    New Microbiol; 2015 Jul; 38(3):387-92. PubMed ID: 26147151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbapenemases and extended-spectrum β-lactamases producing Enterobacteriaceae isolated from Tunisian and Libyan hospitals.
    Mathlouthi N; Al-Bayssari C; El Salabi A; Bakour S; Ben Gwierif S; Zorgani AA; Jridi Y; Ben Slama K; Rolain JM; Chouchani C
    J Infect Dev Ctries; 2016 Aug; 10(7):718-27. PubMed ID: 27482803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of carbapenemase and mcr-1 genes in carbapenem-resistant Klebsiella pneumoniae isolates.
    Arabacı Ç; Dal T; Başyiğit T; Genişel N; Durmaz R
    J Infect Dev Ctries; 2019 Jun; 13(6):504-509. PubMed ID: 32058985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced ceftazidime and ertapenem susceptibility due to production of OXA-2 in Klebsiella pneumoniae ST258.
    Iovleva A; Mettus RT; McElheny CL; Mustapha MM; Van Tyne D; Shields RK; Pasculle AW; Cooper VS; Doi Y
    J Antimicrob Chemother; 2019 Aug; 74(8):2203-2208. PubMed ID: 31127290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The Epidemiology of Carbapenemases in Escherichia coli and Klebsiella pneumoniae Isolated in 2019 in Turkey].
    Süzük Yıldız S; Şimşek H; Bakkaloğlu Z; Numanoğlu Çevik Y; Hekimoğlu CH; Kılıç S; Alp Meşe E;
    Mikrobiyol Bul; 2021 Jan; 55(1):1-16. PubMed ID: 33590977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology and genomic analysis of Klebsiella oxytoca from a single hospital network in Australia.
    Stewart J; Judd LM; Jenney A; Holt KE; Wyres KL; Hawkey J
    BMC Infect Dis; 2022 Aug; 22(1):704. PubMed ID: 36002802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early OXA-48-Producing
    Gijón D; Tedim AP; Valverde A; Rodríguez I; Morosini MI; Coque TM; Manrique M; Pareja E; Tobes R; Ruiz-Garbajosa P; Cantón R
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32269151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular characterization of carbapenemase producing Klebsiella pneumoniae strains by multiplex PCR and PFGE methods: The first K.pneumoniae isolates co-producing OXA-48/KPC and KPC/NDM in Turkey.
    Genç S; Kolaylı F; Özçelik EY
    J Infect Chemother; 2022 Feb; 28(2):192-198. PubMed ID: 34711509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The emergence of OXA-48- and NDM-1-positive Klebsiella pneumoniae in Riyadh, Saudi Arabia.
    Shibl A; Al-Agamy M; Memish Z; Senok A; Khader SA; Assiri A
    Int J Infect Dis; 2013 Dec; 17(12):e1130-3. PubMed ID: 24021566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands.
    Sturm PD; Bochum ET; van Mook-Vermulst SV; Handgraaf C; Klaassen T; Melchers WJ
    Microb Drug Resist; 2010 Mar; 16(1):55-60. PubMed ID: 20001741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of VIM, NDM and OXA-48 producing carbapenem resistant Enterobacterales among clinical isolates in Southern Hungary.
    Gajdács M; Ábrók M; Lázár A; Jánvári L; Tóth Á; Terhes G; Burián K
    Acta Microbiol Immunol Hung; 2020 Dec; 67(4):209-215. PubMed ID: 33258795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidrug-resistant Klebsiella pneumoniae harboring extended spectrum β-lactamase encoding genes isolated from human septicemias.
    Carvalho I; Chenouf NS; Carvalho JA; Castro AP; Silva V; Capita R; Alonso-Calleja C; Enes Dapkevicius MLN; Igrejas G; Torres C; Poeta P
    PLoS One; 2021; 16(5):e0250525. PubMed ID: 33945553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. OXA-48-Like-Producing Klebsiella pneumoniae in Southern Spain in 2014-2015.
    Machuca J; López-Cerero L; Fernández-Cuenca F; Mora-Navas L; Mediavilla-Gradolph C; López-Rodríguez I; Pascual Á
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30323046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of β-lactamase genes among carbapenem-resistant Klebsiella pneumoniae strains isolated from patients in Turkey.
    Iraz M; Özad Düzgün A; Sandallı C; Doymaz MZ; Akkoyunlu Y; Saral A; Peleg AY; Özgümüş OB; Beriş FŞ; Karaoğlu H; Çopur Çiçek A
    Ann Lab Med; 2015 Nov; 35(6):595-601. PubMed ID: 26354347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of WGS data for investigation of a long-term NDM-1-producing Citrobacter freundii outbreak and secondary in vivo spread of blaNDM-1 to Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca.
    Hammerum AM; Hansen F; Nielsen HL; Jakobsen L; Stegger M; Andersen PS; Jensen P; Nielsen TK; Hansen LH; Hasman H; Fuglsang-Damgaard D
    J Antimicrob Chemother; 2016 Nov; 71(11):3117-3124. PubMed ID: 27494919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diffusion of OXA-48 carbapenemase among urinary isolates of Klebsiella pneumoniae in non-hospitalized elderly patients.
    Šuto S; Bedenić B; Likić S; Kibel S; Anušić M; Tičić V; Zarfel G; Grisold A; Barišić I; Vraneš J
    BMC Microbiol; 2022 Jan; 22(1):30. PubMed ID: 35045829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbapenem resistance due to Bla(OXA-48) among ESBL-producing Escherichia coli and Klebsiella pneumoniae isolates in a univesity hospital, Turkey.
    Nazik H; Ongen B; Ilktac M; Aydin S; Kuvat N; Sahin A; Yemisen M; Mete B; Durmus MS; Balkan II; Yildiz I; Ergul Y
    Southeast Asian J Trop Med Public Health; 2012 Sep; 43(5):1178-85. PubMed ID: 23431824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High proportion of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae among extended-spectrum β-lactamase-producers in Nigerian hospitals.
    Olalekan A; Onwugamba F; Iwalokun B; Mellmann A; Becker K; Schaumburg F
    J Glob Antimicrob Resist; 2020 Jun; 21():8-12. PubMed ID: 31525542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamics and molecular features of OXA-48-like-producing Klebsiella pneumoniae lineages in a Tunisian hospital.
    Messaoudi A; Haenni M; Bouallègue O; Saras E; Chatre P; Chaouch C; Boujâafar N; Mansour W; Madec JY
    J Glob Antimicrob Resist; 2020 Mar; 20():87-93. PubMed ID: 31306816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Confronting Ceftolozane-Tazobactam Susceptibility in Multidrug-Resistant Enterobacterales Isolates and Whole-Genome Sequencing Results (STEP Study).
    Hernández-García M; García-Fernández S; García-Castillo M; Melo-Cristino J; Pinto MF; Gonçalves E; Alves V; Costa E; Ramalheira E; Sancho L; Diogo J; Ferreira R; Silva T; Chaves C; Pássaro L; Paixão L; Romano J; Cantón R;
    Int J Antimicrob Agents; 2021 Feb; 57(2):106259. PubMed ID: 33310115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.